Their timing for announcement release was pretty shit. This one...

Their timing for announcement release was pretty shit. This one should have been released immediately after the update announcement and both should have been released earlier to give investors time to read and understand the information. This announcement gives more detail and clarity than the first and would have lessened the current price damage.
obviously not thrilled by the results but does show the drug is effective on sicker patients and is therefore going to be good. Company still has a lot of potential, still has cash but will need a pharmacy deal (which is probably less likely now) or significant cap raise to fund future development.
Been in the bottom drawer for three years now and back she goes. Won’t be selling yet. Covid19 could be the game changer.